相关实验视频

Updated: May 7, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

阿司匹林在预防胃肠道癌症中的作用

Maryam Ibrahim¹, Janusz Jankowski^2,3,4

¹GI Department, University Hospitals Leicester, Leicester, UK.

Gastrointestinal oncology (Philadelphia, Pa.)

|January 6, 2025

概括

阿司匹林在减少胃肠 (GI) 癌症发生方面表现有前途,特别是在结肠中. 需要进行进一步的研究,以优化其用于肠道癌化学预防的使用,并确定有风险的人群.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
预防医学预防医学

背景情况:

癌症是一个日益严重的全球健康问题,胃肠道 (GI) 癌症导致大量癌症死亡.
化疗预防是预防胃肠道癌症的新兴策略,与饮食改变和查一起.
阿司匹林已证明在减少结肠癌发病率方面具有有效性.

研究的目的:

探索阿司匹林作为肠胃癌的化学预防剂的潜力.
确定实施阿司匹林用于胃肠道癌症预防的必要步骤,包括风险效益分析和人口选择.
为制定国家使用阿司匹林在胃肠道化学预防中的指导方针提供信息.

主要方法:

随机对照试验和关于阿司匹林对癌症发生的影响的人口研究的综述.
关于阿司匹林适用于包括食道在内的各种胃肠道部位的证据分析.
考虑阿司匹林在肠道癌的初级预防和辅助治疗中实施的因素.

主要成果:

有力的证据支持阿司匹林在显著减少结肠癌发生的作用 (减少10-45%).
阿司匹林的潜在益处可能扩展到其他肠道部位,如食道.
需要优化风险/益处概况,并选择适合阿司匹林使用的患者群体.

结论:

阿司匹林为肠道癌的化疗预防提供了一个可行的选择,特别是结肠癌.
进一步的研究和指导方针的制定对于阿司匹林在肠道癌症管理中的有效实施至关重要.
考虑个体风险和益处的个性化方法对于阿司匹林在消化道癌症预防中的作用至关重要.

关键词:

癌症癌症癌症癌症癌症预防癌症预防癌症化学预防化学预防结肠直肠癌是什么意思这是食道癌的癌症.

更多相关视频

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

相关概念视频

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...